
    
      The treatment period is 12 weeks. The day after subjects who meet the inclusion criteria
      undergo baseline examination is the day starting the medication. The dosing frequency was six
      times daily for 3% Diquafosol Ophthalmic Solution. The follow-up time points are 2, 4, 8, 12
      weeks, and the investigator will evaluate the symptoms and signs of Dry Eye.
    
  